$IBB News Another bear market for froth stocks? 3:03

New Post Public Reply Private Reply Replies (0) Message Board

Jul 18, 2014 at 10:46 AM

$IBB News

Another bear market for froth stocks? 3:03 p.m. July 17, 2014 - John Nyaradi
U.S. stocks gain; Dow sets its 15th record of the year 4:03 p.m. July 16, 2014 - Barbara Kollmeyer
U.S. stocks close lower; Dow ekes out a gain 4:16 p.m. July 15, 2014 - Barbara Kollmeyer
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Social-media and biotech stocks weaker after Fed warning 10:23 a.m. July 15, 2014 - Steve Goldstein
U.S. stocks fall; momentum plays hit hard 4:20 p.m. July 8, 2014 - Barbara Kollmeyer
Dow falls by triple digits, closes back under 17,000: stock market live blog recap 3:51 p.m. July 8, 2014 - blogs.marketwatch.com
Momentum mauled: Biotech, Facebook, Twitter hit hard 12:32 p.m. July 8, 2014 - blogs.marketwatch.com
S&P 500, Dow Industrials log first losses in July: live blog recap 4:12 p.m. July 7, 2014 - blogs.marketwatch.com
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
S&P 500 closes at record after shaking off early loss: stock market live blog recap 3:45 p.m. June 4, 2014 - blogs.marketwatch.com
Stocks could fall 15% to 20% as 'QE fluff' comes out of the market 3:00 p.m. May 29, 2014 - blogs.marketwatch.com
S&P 500 digests break to uncharted territory 10:53 a.m. May 28, 2014 - Michael Ashbaugh
Bulls cherry pick data 10:02 p.m. May 22, 2014 - Dave Fry
Dow closes down 101 points; Russell 2000 off 1.5% (Stock market live blog) 4:21 p.m. May 14, 2014 - blogs.marketwatch.com
S&P 500, Dow eke out record closes; Nasdaq loses ground: stock market live blog recap 3:25 p.m. May 13, 2014 - blogs.marketwatch.com
Tech, small-cap stock slide may give way to M&A rush 8:31 a.m. May 11, 2014 - Wallace Witkowski
Small-caps’ slide reflects a market in trouble 5:01 a.m. May 9, 2014 - Dave Fry
Small caps, biotech buckle; Dow trims big gain: Stock market live blog recap 4:02 p.m. May 8, 2014 - blogs.marketwatch.com
Momentum stocks like Tesla, Twitter and Yelp are taking a beating Tuesday 3:37 p.m. May 6, 2014 - blogs.marketwatch.com

Why Are Market Insiders So Worried? 11:37 a.m. July 17, 2014 - InvestorPlace.com
The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary 10:00 a.m. July 17, 2014 - Zacks.com
Bulls Rejoice! Strong Dow Theory Buy Signal Issued 9:25 p.m. July 16, 2014 - InvestorPlace.com
Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market 11:40 a.m. July 16, 2014 - TheStreet.com
Yellen Calls Out Speculative Highfliers 11:38 a.m. July 16, 2014 - Barrons.com
Over Exuberant Market Could Still Produce Bargains 9:44 p.m. July 15, 2014 - InvestorPlace.com
Yellen's Remarks Sink Small Stocks 6:43 p.m. July 15, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation 4:19 p.m. July 15, 2014 - TheStreet.com
Fed: These Two Industries Look Overvalued - Real Time Insight 2:29 p.m. July 15, 2014 - Zacks.com
Physician payment data to be made public on September 30 1:56 p.m. July 15, 2014 - Seeking Alpha
Fed report depresses biotechs 1:22 p.m. July 15, 2014 - Seeking Alpha
Fed Chair Yellen Says Small Biotech Stocks Over-Valued 1:10 p.m. July 15, 2014 - TheStreet.com
Stock Market Today: Biotech, Social Media Stocks Slide Following Yellen's Remarks 12:14 p.m. July 15, 2014 - TheStreet.com
Yellen Says Social Media, Biotech Stocks 'Substantially Stretched' 11:11 a.m. July 15, 2014 - benzinga.com
Yellen warns on small cap and momo sector valuations 10:32 a.m. July 15, 2014 - Seeking Alpha
Yellen Sees Social Media, Biotech, Junk Bonds and Leveraged Loans Overvalued 10:30 a.m. July 15, 2014 - 247WallSt.com
Ebola outbreak in West Africa uncontained 9:48 a.m. July 11, 2014 - Seeking Alpha
'Fast Money' Recap: Confusion in the Market 5:00 a.m. July 11, 2014 - TheStreet.com
Pros And Cons Of Tactical Allocation Explained With A Real Trade 4:57 p.m. July 10, 2014 - Seeking Alpha
10 Best And 10 Worst Net Capture Ratio ETFs Over Trailing 3 Years 2:18 p.m. July 10, 2014 - Seeking Alpha

Premier Biomedical Advances Technology via Partnerships 10:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 9:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 9:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 6:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 8:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 8:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 8:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 12:06 p.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 8:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 8:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 8:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 8:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 9:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 8:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 8:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 8:52 a.m. July 17, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Orbis Celebrates 20 Years of Eye Care in Macau

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Ramaco Resources Faces Stock Shake-Up Amid Distribution

Stock Shake-Up In The Coal Industry Something's brewing in the coal mines of West Virginia, and it isn't just the usual dust settling. Ramaco Resources, Inc. (NASDAQ: METC), the metallurgical coal titan, is feeling the heat from some unexpected stock market turbulence, and it's got everyone in the investment trenches scratching their heads. The Yorktown Energy Partners'...

What to Expect from KeyCorp at Barclays Event

KeyCorp's Next Move: An Insider's View Yep, circle that calendar, folks. Looks like KeyCorp's gonna be laying it all out there for the financial world to see. Clark Khayat, their numero uno money guy, is hitting the stage at the Barclays Global Financial Services Conference on Sept. 14. So grab the popcorn—or, more like, your portfolio tracker—because this could get...

Charity's Bold Move: Acquiring Wayfinder for K-12 Impact

Public Charity Expands Into Education Well, here's something that's bound to turn a few heads: a fast-growing public charity has just made its first acquisition in the K-12 sphere by snapping up Wayfinder. The stakes are getting interesting. When a charity starts playing in the acquisition space, you're looking at a change in strategy that deserves close attention. Why...

YSL Beauty’s Block Party Series Rocks London's Scene

YSL Beauty: More Than a Brand, a Cultural Movement London felt a distinct pulse this past weekend as YSL Beauty kicked off another sizzling event in its Block Party series. This one wasn't just another Instagrammable gathering; it was the kind of scene that shifted the cultural needle. What started in Madrid has now become a roving spectacle that sweeps across cities,...

XTEND Launches on NYSE Amid Market Milestones

XTEND Steps Into the NYSE Spotlight Out of the gate, let's talk about XTEND—a name that's about to make waves on the New York Stock Exchange. With their debut under the ticker XTND, these folks are slamming their flag into the financial terrain like a knight ready for battle. XTEND, an AI-powered defense robotics and software outfit, isn't just joining the party—it's...

Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Ed Markey's Political Future on Shaky Ground in MA

Massachusetts Voters Voice Desire for Change Ever seen an old engine stutter and cough before finally quitting? That's what Ed Markey's political career is starting to feel like. A fresh poll has surfaced, casting doubt over his steady grip on his longstanding Senate seat in Massachusetts. People are yearning for fresh faces and new ideas like never before. It's as if the...

Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Parents Champion Meta's Online Safety Agreement

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....